Učitavanje...

The effect of recombinant human erythropoietin treatment on tumour radiosensitivity and cancer-associated anaemia in the mouse.

Recombinant human erythropoietin (rHuEpo) has recently become available for the treatment of chronic anaemia, including that associated with cancer. Carcinoma NT in CBA mice causes a progressive anaemia which can be overcome by daily injections of recombinant human erythropoietin (rHuEpo). This mode...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Joiner, B., Hirst, V. K., McKeown, S. R., McAleer, J. J., Hirst, D. G.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 1993
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1968603/
https://ncbi.nlm.nih.gov/pubmed/8398699
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!